High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination.
Anglero-Rodriguez YI, Lempp FA, Subramanian M, McIninch J, Schlegel MK, Bohan D, Wong E, Brown CR, Foster DJ, Castoreno AB, Nguyen T, Cuffe D, Montiel-Ruiz M, Kaiser H, Sahakyan A, Spreafico R, Morskaya SS, Barry JD, Berman D, Zhang L, Lefebvre S, Kasper A, Racie T, Weddle D, Mobley M, Wassarman K, Bisbe A, Zlatev I, Rogers A, Nechev L, Dybowski J, Chong S, Nair J, Simon A, Sloan K, Hwang S, Virgin HW, Fitzgerald K, Maier MA, Hinkle G, Hebner CM, Akinc A, Jadhav V.
Anglero-Rodriguez YI, et al. Among authors: dybowski j.
Nucleic Acids Res. 2025 Jan 7;53(1):gkae1195. doi: 10.1093/nar/gkae1195.
Nucleic Acids Res. 2025.
PMID: 39657790